Hospitals | December 12, 2025
Dr Agarwals Eye Hospital expands global footprint with advanced centre in Mauritius
The new centre brings advanced corneal procedures pioneered in India
The new centre brings advanced corneal procedures pioneered in India
At the trial’s pre-specified interim analysis, giredestrant achieved a hazard ratio of 0.70, marking a statistically significant improvement in invasive disease-free survival
Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045
The FDA aims to make a decision by April 8, 2026
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
This is the first approval of a prescription transdermal dosage Form in the European markets from this facility
Zyrifa is indicated for patients with bone metastases stemming from a wide range of solid tumors
The new site marks the company’s first operation in the region
Dr Reddy’s will pay Immutep US$ 20 million upfront and could deliver as much as US$ 349.5 million in regulatory and commercial milestones
The patented product, developed by Venus Medicine Research Centre (VMRC) for the treatment of multidrug-resistant (MDR) infections, was sold to Cipla in 2019
Subscribe To Our Newsletter & Stay Updated
